EP1729768 - IMMUNE RESPONSE MODIFIER FORMULATIONS AND METHODS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.11.2018 Database last updated on 09.09.2024 | |
Former | The patent has been granted Status updated on 08.12.2017 | ||
Former | Grant of patent is intended Status updated on 24.10.2017 | Most recent event Tooltip | 05.06.2020 | Lapse of the patent in a contracting state New state(s): HU, PT | published on 08.07.2020 [2020/28] | Applicant(s) | For all designated states Meda AB Pipers väg 2A Box 906 170 09 Solna / SE | [2018/02] |
Former [2014/52] | For all designated states Meda AB Pipers väg 2A Box 906 170 09 Solna / SE | ||
Former [2006/50] | For all designated states 3M Innovative Properties Company 3M Center, P.O. Box 33427 St. Paul, MN 55133-3427 / US | Inventor(s) | 01 /
BUSCH, Terri F. Post Office Box 33427 Saint Paul, MN 55133-3427 / US | 02 /
KUEPER, Leo W., III Post Office Box 33427 Saint Paul, MN 55133-3427 / US | [2006/50] | Representative(s) | FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 / IE | [N/P] |
Former [2018/02] | FRKelly 27 Clyde Road Dublin D04 F838 / IE | ||
Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
Former [2006/50] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 05725623.2 | 14.03.2005 | [2006/50] | WO2005US08576 | Priority number, date | US20040553148P | 15.03.2004 Original published format: US 553148 P | [2006/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2005089317 | Date: | 29.09.2005 | Language: | EN | [2005/39] | Type: | A2 Application without search report | No.: | EP1729768 | Date: | 13.12.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.09.2005 takes the place of the publication of the European patent application. | [2006/50] | Type: | B1 Patent specification | No.: | EP1729768 | Date: | 10.01.2018 | Language: | EN | [2018/02] | Search report(s) | International search report - published on: | US | 27.07.2006 | (Supplementary) European search report - dispatched on: | EP | 30.09.2013 | Classification | IPC: | A61K31/44, A61K9/107 | [2013/44] | CPC: |
A61K31/202 (EP,US);
A61K31/4375 (EP,US);
A61K31/4745 (EP,US);
A61K9/0014 (EP,US);
A61K9/107 (EP,US);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/12 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
|
Former IPC [2006/50] | A61K31/44 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2018/02] |
Former [2006/50] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | FORMULIERUNGEN UND VERFAHREN ZUR MODIFIZIERUNG DER IMMUNANTWORT | [2006/50] | English: | IMMUNE RESPONSE MODIFIER FORMULATIONS AND METHODS | [2006/50] | French: | FORMULATIONS MODIFICATRICES DE REPONSE IMMUNITAIRE ET PROCEDES CORRESPONDANTS | [2006/50] | Entry into regional phase | 21.09.2006 | National basic fee paid | 21.09.2006 | Search fee paid | 21.09.2006 | Designation fee(s) paid | 21.09.2006 | Examination fee paid | Examination procedure | 21.09.2006 | Amendment by applicant (claims and/or description) | 21.09.2006 | Examination requested [2006/50] | 10.02.2014 | Despatch of a communication from the examining division (Time limit: M06) | 20.08.2014 | Reply to a communication from the examining division | 16.02.2016 | Despatch of a communication from the examining division (Time limit: M06) | 26.08.2016 | Reply to a communication from the examining division | 25.10.2017 | Communication of intention to grant the patent | 01.12.2017 | Fee for grant paid | 01.12.2017 | Fee for publishing/printing paid | 01.12.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.02.2014 | Opposition(s) | 11.10.2018 | No opposition filed within time limit [2018/51] | Fees paid | Renewal fee | 28.03.2007 | Renewal fee patent year 03 | 27.03.2008 | Renewal fee patent year 04 | 27.03.2008 | Renewal fee patent year 05 | 25.03.2010 | Renewal fee patent year 06 | 15.03.2011 | Renewal fee patent year 07 | 14.03.2012 | Renewal fee patent year 08 | 11.03.2013 | Renewal fee patent year 09 | 12.03.2014 | Renewal fee patent year 10 | 17.06.2015 | Renewal fee patent year 11 | 18.03.2016 | Renewal fee patent year 12 | 20.02.2017 | Renewal fee patent year 13 | Penalty fee | Additional fee for renewal fee | 31.03.2015 | 11   M06   Fee paid on   17.06.2015 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 14.03.2005 | AT | 10.01.2018 | CY | 10.01.2018 | CZ | 10.01.2018 | DK | 10.01.2018 | EE | 10.01.2018 | FI | 10.01.2018 | LT | 10.01.2018 | MC | 10.01.2018 | NL | 10.01.2018 | PL | 10.01.2018 | PT | 10.01.2018 | RO | 10.01.2018 | SE | 10.01.2018 | SI | 10.01.2018 | SK | 10.01.2018 | TR | 10.01.2018 | IE | 14.03.2018 | LU | 14.03.2018 | BE | 31.03.2018 | CH | 31.03.2018 | LI | 31.03.2018 | BG | 10.04.2018 | GR | 11.04.2018 | IS | 10.05.2018 | [2020/27] |
Former [2020/16] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
CZ | 10.01.2018 | ||
DK | 10.01.2018 | ||
EE | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
MC | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
RO | 10.01.2018 | ||
SE | 10.01.2018 | ||
SI | 10.01.2018 | ||
SK | 10.01.2018 | ||
TR | 10.01.2018 | ||
IE | 14.03.2018 | ||
LU | 14.03.2018 | ||
BE | 31.03.2018 | ||
CH | 31.03.2018 | ||
LI | 31.03.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2019/12] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
CZ | 10.01.2018 | ||
DK | 10.01.2018 | ||
EE | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
MC | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
RO | 10.01.2018 | ||
SE | 10.01.2018 | ||
SI | 10.01.2018 | ||
SK | 10.01.2018 | ||
IE | 14.03.2018 | ||
LU | 14.03.2018 | ||
BE | 31.03.2018 | ||
CH | 31.03.2018 | ||
LI | 31.03.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2019/09] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
CZ | 10.01.2018 | ||
DK | 10.01.2018 | ||
EE | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
MC | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
RO | 10.01.2018 | ||
SE | 10.01.2018 | ||
SK | 10.01.2018 | ||
IE | 14.03.2018 | ||
LU | 14.03.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2019/04] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
CZ | 10.01.2018 | ||
DK | 10.01.2018 | ||
EE | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
MC | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
RO | 10.01.2018 | ||
SE | 10.01.2018 | ||
SK | 10.01.2018 | ||
LU | 14.03.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2018/52] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
CZ | 10.01.2018 | ||
DK | 10.01.2018 | ||
EE | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
MC | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
RO | 10.01.2018 | ||
SE | 10.01.2018 | ||
SK | 10.01.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2018/51] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
CZ | 10.01.2018 | ||
DK | 10.01.2018 | ||
EE | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
RO | 10.01.2018 | ||
SE | 10.01.2018 | ||
SK | 10.01.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2018/50] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
CZ | 10.01.2018 | ||
EE | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
RO | 10.01.2018 | ||
SE | 10.01.2018 | ||
SK | 10.01.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2018/49] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
EE | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
RO | 10.01.2018 | ||
SE | 10.01.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2018/40] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
SE | 10.01.2018 | ||
BG | 10.04.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2018/39] | AT | 10.01.2018 | |
CY | 10.01.2018 | ||
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
SE | 10.01.2018 | ||
GR | 11.04.2018 | ||
IS | 10.05.2018 | ||
Former [2018/37] | CY | 10.01.2018 | |
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
GR | 11.04.2018 | ||
Former [2018/36] | CY | 10.01.2018 | |
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
NL | 10.01.2018 | ||
PL | 10.01.2018 | ||
Former [2018/35] | CY | 10.01.2018 | |
FI | 10.01.2018 | ||
LT | 10.01.2018 | ||
NL | 10.01.2018 | ||
Former [2018/34] | FI | 10.01.2018 | |
LT | 10.01.2018 | ||
NL | 10.01.2018 | Documents cited: | Search | [Y]WO0026217 (BYK GULDEN LOMBERG CHEM FAB [DE], et al) [Y] 1-14 * examples 1-6 * * page 28, paragraph 2 *; | [Y]WO03045391 (3M INNOVATIVE PROPERTIES CO [US]) [Y] 1-14 * page 4, line 13 - line 17 * * claims 1-21 * * examples 136-140 *; | [A] - CHOLLET J L ET AL, "DEVELOPMENT OF A TOPICALLY ACTIVE IMIQUIMOD FORMULATION", PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, NEW YORK, NY, US, (19990101), vol. 4, no. 1, doi:10.1081/PDT-100101337, ISSN 1083-7450, pages 35 - 43, XP000900717 [A] 1-14 * abstract * * page 36, column 1, paragraph 5 * DOI: http://dx.doi.org/10.1081/PDT-100101337 | International search | [Y]US5238944 (SCHULTZ HELEN J [US], et al); | [Y]US6194425 (GERSTER JOHN F [US], et al); | [Y]US6245776 (SKWIERCZYNSKI RAYMOND D [US], et al) | by applicant | US4689338 | US4929624 | EP0394026 | US4988815 | US5037986 | US5175296 | US5238944 | US5266575 | US5268376 | US5346905 | US5352784 | US5367076 | US5389640 | US5395937 | US5446153 | US5482936 | US5693811 | US5741908 | US5756747 | US5939090 | US6039969 | US6069149 | US6083505 | US6110929 | US6194425 | US6245776 | US6331539 | US2002016332 | US6376669 | US2002055517 | US2002110840 | US6451810 | US6518265 | US6525064 | US6541485 | US6545016 | US6545017 | US6558951 | US6573273 | US2003133913 | US2003161797 | US2003199538 | US6656938 | US6660735 | US6660747 | US6664260 | US6664264 | US6664265 | US6667312 | US6670372 | US6677347 | US6677348 | US6677349 | US2004014779 | US6683088 | US6743920 | US6756382 | US2004147543 | US2004175336 | US2004176367 | US2004180919 | US2004181130 | US2004181211 | US6797718 | US2004192585 | US6818650 |